Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 228

1.

Integrated Diagnosis Project for Inflammatory Myopathies: An association between autoantibodies and muscle pathology.

Suzuki S, Uruha A, Suzuki N, Nishino I.

Autoimmun Rev. 2017 Jul;16(7):693-700. doi: 10.1016/j.autrev.2017.05.003. Epub 2017 May 4. Review.

PMID:
28479486
2.

[Autoantibodies of Inflammatory Myopathies: Update].

Suzuki S.

Brain Nerve. 2016 Dec;68(12):1443-1451. Japanese.

PMID:
27916754
3.

Skeletal Muscle Involvement in Antisynthetase Syndrome.

Noguchi E, Uruha A, Suzuki S, Hamanaka K, Ohnuki Y, Tsugawa J, Watanabe Y, Nakahara J, Shiina T, Suzuki N, Nishino I.

JAMA Neurol. 2017 Aug 1;74(8):992-999. doi: 10.1001/jamaneurol.2017.0934.

4.

Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.

Mariampillai K, Granger B, Amelin D, Guiguet M, Hachulla E, Maurier F, Meyer A, Tohmé A, Charuel JL, Musset L, Allenbach Y, Benveniste O.

JAMA Neurol. 2018 Dec 1;75(12):1528-1537. doi: 10.1001/jamaneurol.2018.2598.

5.

[Myositis-specific autoantibodies].

Fujimoto M.

Brain Nerve. 2013 Apr;65(4):449-60. Review. Japanese.

PMID:
23568993
6.

Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.

Mescam-Mancini L, Allenbach Y, Hervier B, Devilliers H, Mariampillay K, Dubourg O, Maisonobe T, Gherardi R, Mezin P, Preusse C, Stenzel W, Benveniste O.

Brain. 2015 Sep;138(Pt 9):2485-92. doi: 10.1093/brain/awv192. Epub 2015 Jul 21.

PMID:
26198592
7.

Peculiar clinicopathological features of immune-mediated necrotizing myopathies.

Allenbach Y, Benveniste O.

Curr Opin Rheumatol. 2018 Nov;30(6):655-663. doi: 10.1097/BOR.0000000000000547. Review.

PMID:
30239349
8.

Nuclear actin aggregation is a hallmark of anti-synthetase syndrome-induced dysimmune myopathy.

Stenzel W, Preuße C, Allenbach Y, Pehl D, Junckerstorff R, Heppner FL, Nolte K, Aronica E, Kana V, Rushing E, Schneider U, Claeys KG, Benveniste O, Weis J, Goebel HH.

Neurology. 2015 Mar 31;84(13):1346-54. doi: 10.1212/WNL.0000000000001422. Epub 2015 Mar 6.

9.

Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.

Mammen AL.

Nat Rev Neurol. 2011 Jun 8;7(6):343-54. doi: 10.1038/nrneurol.2011.63. Review.

PMID:
21654717
10.

Autoantibodies in polymyositis and dermatomyositis.

Ghirardello A, Bassi N, Palma L, Borella E, Domeneghetti M, Punzi L, Doria A.

Curr Rheumatol Rep. 2013 Jun;15(6):335. doi: 10.1007/s11926-013-0335-1. Review.

PMID:
23591825
11.

[Diagnosis of Idiopathic Inflammatory Myopathy: A Muscle Pathology Perspective].

Inoue M, Nishino I.

Brain Nerve. 2016 Dec;68(12):1431-1441. Japanese.

PMID:
27916753
12.

Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.

Troyanov Y, Targoff IN, Payette MP, Raynauld JP, Chartier S, Goulet JR, Bourré-Tessier J, Rich E, Grodzicky T, Fritzler MJ, Joyal F, Koenig M, Senécal JL.

Medicine (Baltimore). 2014 Nov;93(24):318-32. doi: 10.1097/MD.0000000000000222. Erratum in: Medicine (Baltimore). 2014 Nov;93(24):414.

13.

Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.

Watanabe Y, Uruha A, Suzuki S, Nakahara J, Hamanaka K, Takayama K, Suzuki N, Nishino I.

J Neurol Neurosurg Psychiatry. 2016 Oct;87(10):1038-44. doi: 10.1136/jnnp-2016-313166. Epub 2016 May 4.

PMID:
27147697
14.

Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan.

Watanabe Y, Suzuki S, Nishimura H, Murata KY, Kurashige T, Ikawa M, Asahi M, Konishi H, Mitsuma S, Kawabata S, Suzuki N, Nishino I.

Medicine (Baltimore). 2015 Jan;94(4):e416. doi: 10.1097/MD.0000000000000416.

15.

Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review.

Mahler M, Miller FW, Fritzler MJ.

Autoimmun Rev. 2014 Apr-May;13(4-5):367-71. doi: 10.1016/j.autrev.2014.01.022. Epub 2014 Jan 11. Review.

16.

[How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies].

Sibilia J, Chatelus E, Meyer A, Gottenberg JE, Sordet C, Goetz J.

Presse Med. 2010 Oct;39(10):1010-25. doi: 10.1016/j.lpm.2010.06.008. Epub 2010 Jul 23. French.

PMID:
20655695
17.

RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositis.

Suárez-Calvet X, Gallardo E, Pinal-Fernandez I, De Luna N, Lleixà C, Díaz-Manera J, Rojas-García R, Castellví I, Martínez MA, Grau JM, Selva-O'Callaghan A, Illa I.

Arthritis Res Ther. 2017 Jul 24;19(1):174. doi: 10.1186/s13075-017-1383-0.

18.

[Inflammatory myopathies: diagnosis and classifications].

Dimitri D.

Presse Med. 2009 Jul-Aug;38(7-8):1141-63. doi: 10.1016/j.lpm.2009.01.013. Epub 2009 Mar 17. Review. French.

PMID:
19282137
19.

Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies.

Ladislau L, Arouche-Delaperche L, Allenbach Y, Benveniste O.

Curr Rheumatol Rep. 2018 Aug 3;20(9):56. doi: 10.1007/s11926-018-0763-z. Review.

PMID:
30074107
20.

Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays.

Damoiseaux J, Vulsteke JB, Tseng CW, Platteel ACM, Piette Y, Shovman O, Bonroy C, Hamann D, De Langhe E, Musset L, Chen YH, Shoenfeld Y, Allenbach Y, Bossuyt X.

Autoimmun Rev. 2019 Mar;18(3):293-305. doi: 10.1016/j.autrev.2018.10.004. Epub 2019 Jan 11. Review.

PMID:
30639643

Supplemental Content

Support Center